Healthcare - Biotechnology - NASDAQ - US
$ 59.69
-0.0837 %
$ 2.33 B
Market Cap
-26.53
P/E
INCOME STATEMENT
0
REVENUE
-56.8 M
OPERATING INCOME
-54.4 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Longboard Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 5 K |
| Gross Profit | -5 K |
| Operating Expenses | 56.8 M |
| Operating Income | -56.8 M |
| Other Expenses | -2.34 M |
| Net Income | -54.4 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 5 K | 5 K | 1 K | 0 |
| Gross Profit | 5 K | 5 K | 1 K | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 56.8 | 44.8 | 27.8 | 14.4 |
| Selling, General and Administrative Expenses | 13.0 | 10.2 | 8.1 | 9.8 |
| Research and Development Expenses | 43.8 | 34.6 | 19.8 | 4.6 |
| Operating Income | (56.8) | (44.8) | (27.8) | (14.4) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0 | 0.8 | 0 | 0 |
| Total Other Income | 2.3 | 0.9 | 42 K | 0 |
| Pre-Tax Income | (54.4) | (43.9) | (27.8) | (14.4) |
| NET INCOME | ||||
| Tax Provision | 0 | (0.9) | 64 K | 14.4 K |
| Net Income | (54.4) | (43.1) | (27.7) | (14.4) |
| EPS | 2.39 | 2.51 | 1.62 | 0.82 |